Esperion Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Esperion Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.0M | 549k | 3.70 |
| 2025-09-30 | $1.2M | 463k | 2.65 |
| 2025-06-30 | $420k | 427k | 0.98 |
| 2025-03-31 | $598k | 415k | 1.44 |
| 2024-12-31 | $941k | 428k | 2.20 |
| 2024-09-30 | $703k | 426k | 1.65 |
| 2024-06-30 | $1.3M | 572k | 2.22 |
| 2024-03-31 | $45k | 17k | 2.68 |
| 2023-12-31 | $195k | 65k | 2.99 |
| 2023-09-30 | $27k | 27k | 0.98 |
| 2023-06-30 | $38k | 28k | 1.39 |
| 2023-03-31 | $453k | 285k | 1.59 |
| 2022-12-31 | $1.8M | 286k | 6.23 |
| 2022-09-30 | $1.6M | 272k | 6.00 |
| 2022-06-30 | $1.5M | 241k | 6.36 |
| 2022-03-31 | $1.0M | 224k | 4.63 |
| 2021-12-31 | $557k | 111k | 5.00 |
| 2021-09-30 | $1.1M | 92k | 12.06 |
| 2021-06-30 | $1.8M | 84k | 21.17 |
| 2021-03-31 | $2.8M | 101k | 28.06 |
| 2020-12-31 | $3.1M | 118k | 26.00 |
| 2020-09-30 | $5.1M | 136k | 37.16 |
| 2020-06-30 | $7.9M | 138k | 57.14 |
| 2020-03-31 | $4.3M | 137k | 31.53 |
| 2019-12-31 | $9.1M | 153k | 59.63 |
| 2019-09-30 | $3.7M | 102k | 36.65 |
| 2019-06-30 | $4.8M | 104k | 46.51 |
| 2019-03-31 | $4.1M | 103k | 40.14 |
| 2018-12-31 | $4.8M | 104k | 46.01 |
| 2018-09-30 | $5.2M | 118k | 44.37 |
| 2018-06-30 | $4.4M | 112k | 39.20 |
| 2018-03-31 | $10M | 142k | 72.33 |
| 2017-12-31 | $7.7M | 116k | 65.85 |
| 2017-06-30 | $5.3M | 115k | 46.26 |
| 2017-03-31 | $3.7M | 105k | 35.31 |
| 2016-12-31 | $1.0M | 81k | 12.53 |
| 2016-09-30 | $850k | 61k | 13.86 |
| 2016-06-30 | $615k | 62k | 9.89 |